Document
type: Class

Academic Article
type: Class

Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis
type: Continuant
related by: 22311369
type: Academic Article
type: Article
type: Generically Dependent Continuant
type: Information Content Entity
most specific type: Academic Article
language: English
type: Document
type: Thing
type: Entity

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Article
type: Class

English
type: Language

22311369
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis

Information Content Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-03T05:41:11
publisher: Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis
type: Document
label: RDF description of Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis - http://irises.unimi.it/resource/item/280404